Evaluation of imaging biomarkers and longitudinal assessment of global and regional cardiac function by cardiac MRI during recovery from COVID-19 infection in a multicenter normalized cohort

Evaluation of imaging biomarkers and longitudinal assessment of global and regional cardiac function by cardiac MRI during recovery from COVID-19 infection in a multicenter normalized cohort - NAHAP-KAM

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028901

Enrollment

150

Registered

2022-06-30

Start date

2022-06-30

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z03.8

Interventions

Group 1: The target population of our study includes previously collected data from patients in the National Pandemic Cohort Network (NAPKON) High Resolution Platform (HAP) cohort in the recovery phas

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients (age: >18 years, no gender or ethnicity restrictions) who underwent one or more cardiac MRI examination(s) as a result of detected COVID-19 acquisition (PCR test) in the NAPKON HAP cohort will be included in the analysis.

Exclusion criteria

Exclusion criteria: - Patients without an existing cardio-MRI examination. - Lack of evidence of COVID-19 disease. - Contraindication to MR imaging (metal, renal insufficiency, lack of compliance)

Design outcomes

Primary

Measure	Time frame
(i) Evaluation of T1 and T2 mapping with respect to the occurrence of MACE (Major Adverse Cardiac Events) (ii) Differences in gcardiac function according to severity of myocardial injury	—

Secondary

Measure	Time frame
Association of anamnestic data with the development of COVID-19-associated myocardial injury.	—

Countries

Germany

Contacts

Public ContactJulia Ruat

Klinik und Poliklinik für Radiologie Klinikum der Universität München Campus Großhadern

julia.ruat@med.uni-muenchen.de(089) 4400-76642

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026